4//SEC Filing
Fink Eric 4
Accession 0000899243-21-009591
CIK 0001629137other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:20 PM ET
Size
14.5 KB
Accession
0000899243-21-009591
Insider Transaction Report
Form 4
Fink Eric
Chief Human Resources Officer
Transactions
- Exercise/Conversion
Common Stock
2021-03-01+3,125→ 5,520 total - Tax Payment
Common Stock
2021-03-01$44.48/sh−859$38,208→ 4,661 total - Exercise/Conversion
Restricted Stock Units
2021-03-01−3,125→ 15,625 total→ Common Stock (3,125 underlying) - Award
Stock Option (Right to Buy)
2021-03-01+38,739→ 38,739 totalExercise: $44.48Exp: 2031-02-28→ Common Stock (38,739 underlying) - Award
Restricted Stock Units
2021-03-01+22,102→ 22,102 total→ Common Stock (22,102 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- [F2]Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 3,125 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]The shares of Common Stock underlying the RSUs vested with respect to 1/4th of the shares on September 1, 2020 and thereafter 1/6th of the remaining underlying shares shall vest in semi-annual installments over 3 years from September 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
- [F4]The shares of Common Stock underlying the option vest in 16 equal quarterly installments over 4 years from March 1, 2021, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
- [F5]The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from March 1, 2021, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001784038
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:20 PM ET
- Size
- 14.5 KB